Clinical Trials
5 trialsNCT05108805 2025-03-27
Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting
Vanderbilt-Ingram Cancer Center
Phase 4 Completed
NCT01990534 2021-04-09
A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma
Takeda
Phase 4 Completed
NCT00003398 2019-10-17
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
University of Maryland, Baltimore
Phase 4 Completed
NCT03376958 2019-07-25
Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma
Zhengzhou University
Phase 4 Completed
NCT00466258 2009-11-25
LINFOTARGAM
PETHEMA Foundation
Phase 4 Completed